The DOI matches its Crossref record; 159 of the 160 references it cites were found in a registry or an index.
Delivery of Therapeutic Proteins
Open accessAbstract
The safety and efficacy of protein therapeutics are limited by three interrelated pharmaceutical issues, in vitro and in vivo instability, immunogenicity and shorter half-lives. Novel drug modifications for overcoming these issues are under investigation and include covalent attachment of poly(ethylene glycol) (PEG), polysialic acid, or glycolic acid, as well as developing new formulations containing nanoparticulate or colloidal systems (e.g., liposomes, polymeric microspheres, polymeric nanoparticles). Such strategies have the potential to develop as next generation protein therapeutics. This review includes a general discussion on these delivery approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PEGylation is widely used in such modification for the delivery of proteins/peptides into the human body.35”
From Catalase-Integrated Hyaluronic Acid as Nanocarriers for Enhanced Photodynamic Therapy in Solid Tumor (2019) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552
Biodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,312
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V. S., Torchilin, V. P., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,951
An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System
Mazmanian, S. K., Liu, C. H., Tzianabos, A. O., & Kasper, D. L. (2005) · Cell · doi:10.1016/j.cell.2005.05.007 · Cited by 2,910
PEGylation, successful approach to drug delivery
Veronese, F. M., & Pasut, G. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03575-0 · Cited by 2,344
Chemistry for peptide and protein PEGylation
Roberts, M. J., Bentley, M. D., & Harris, J. M. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00022-4 · Cited by 1,628
Abuchowski, A., Es, T. V., Palczuk, N. C., & Davis, F. F. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40291-2 · Cited by 1,358
Flagged first, then by citations
1 of the 160 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Kinstler, 1999, N-terminally chemically modified protein compositions and methods, United States Patent 5985265
- Mundargi, 2008, Nano/micro technologies for delivering macro- molecular therapeutics using poly(d, l-lactide-co-glycolide) and its derivatives, J Control Release, 125, 193, 10.1016/j.jconrel.2007.09.013 · DOI · Paper page
Cited by
Sorted by citations
Items 101–200 of 534
Site-Specific PEGylation at Histidine Tags
Cong, Y., Pawlisz, E., Bryant, P., Balan, S., Laurine, E., Tommasi, R., Ruchi, S., Dubey, S., Peciak, K., Bird, M., et al. (2012) · Bioconjugate Chemistry · doi:10.1021/bc200530x · Cited by 84
Bioresponsive transcutaneous patches
Yu, J., Zhang, Y., Kahkoska, A. R., & Gu, Z. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.03.001 · Cited by 84
Smart Mesoporous Silica Nanoparticles for Protein Delivery
Liu, H., & Xu, P. (2019) · Nanomaterials · doi:10.3390/nano9040511 · Cited by 82
Del’Guidice, T., Lepetit-Stoffaes, J.-P., Bordeleau, L., Roberge, J., Théberge, V., Lauvaux, C., Barbeau, X., Trottier, J., Davé, V. P., Roy, D., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195558 · Cited by 84
Aptamers and antibodies in optical biosensing
Mpofu, K. T., Chauke, S. H., Thwala, L. N., & Mthunzi-Kufa, P. T. (2025) · Discover Chemistry. · doi:10.1007/s44371-025-00094-2 · Cited by 80
Mathematical model accurately predicts protein release from an affinity-based delivery system
Vulic, K., Pakulska, M. M., Sonthalia, R., Ramachandran, A., & Shoichet, M. S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.10.032 · Cited by 79
Samra, H. S., & He, F. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200404c · Cited by 77
Polymeric nanoparticles of different sizes overcome the cell membrane barrier
Lerch, S., Dass, M., Musyanovych, A., Landfester, K., & Mailänder, V. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.01.024 · Cited by 76
Synthesis of well-defined protein–polymer conjugates for biomedicine
Zhao, W., Liu, F., Chen, Y., Bai, J., & Gao, W. (2015) · Polymer · doi:10.1016/j.polymer.2015.03.054 · Cited by 79
Protein ROMP: Aqueous Graft-from Ring-Opening Metathesis Polymerization
Isarov, S. A., & Pokorski, J. K. (2015) · ACS Macro Letters · doi:10.1021/acsmacrolett.5b00497 · Cited by 74
Boronic Acid for the Traceless Delivery of Proteins into Cells
Andersen, K. A., Smith, T. P., Lomax, J. E., & Raines, R. T. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00966 · Cited by 73
IL-1Ra and its Delivery Strategies: Inserting the Association in Perspective
Akash, M. S. H., Rehman, K., & Chen, S. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1118-0 · Cited by 74
A Review of Non-Invasive Drug Delivery through Respiratory Routes
Zhang, Y., Xu, D. W., Bai, L., Zhou, Y.-M., Zhang, H., & Cui, Y. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091974 · Cited by 77
Ibrahim, Y. H.-E. Y., Regdon, G., Hamedelniel, E. I., & Sovány, T. (2019) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-019-00316-w · Cited by 71
Particles and powders: Tools of innovation for non-invasive drug administration
Buttini, F., Colombo, P., Rossi, A., Sonvico, F., & Colombo, G. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.02.028 · Cited by 69
Acylase‐containing polyurethane coatings with anti‐biofilm activity
Grover, N., Plaks, J. G., Summers, S. R., Chado, G. R., Schurr, M. J., & Kaar, J. L. (2016) · Biotechnology and Bioengineering · doi:10.1002/bit.26019 · Cited by 68
Drug Delivery Systems Based on Hydroxyethyl Starch
Paleos, C. M., Sideratou, Z., & Tsiourvas, D. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00186 · Cited by 69
On Complex Coacervate Core Micelles: Structure-Function Perspectives
Magaña, J. R., Sproncken, C. C. M., & Voets, I. K. (2020) · Polymers · doi:10.3390/polym12091953 · Cited by 69
Altınoglu, S., Wang, M., & Xu, Q. (2015) · Nanomedicine · doi:10.2217/nnm.14.192 · Cited by 70
Extended release formulations using silk proteins for controlled delivery of therapeutics
Yavuz, B., Chambre, L., & Kaplan, D. L. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1635116 · Cited by 69
Kurniawan, D. W., Booijink, R. S., Pater, L. V., Wols, I., Vrynas, A. V., Storm, G., Prakash, J., & Bansal, R. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.041 · Cited by 72
Shefa, A. A., Taz, M., Lee, S. Y., & Lee, B. (2018) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2018.12.056 · Cited by 67
Comparative Binding of Disulfide-Bridged PEG-Fabs
Khalili, H., Godwin, A., Choi, J.-W., Lever, R., & Brocchini, S. (2012) · Bioconjugate Chemistry · doi:10.1021/bc300372r · Cited by 66
Wang, Y.-J., Larsson, M., Huang, W.-T., Chiou, S., Nicholls, S. J., Chao, J., & Liu, D.-M. (2016) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2016.01.002 · Cited by 65
Trends in Vital Food and Control Engineering
Eissa, A. H. A. (2012) · InTech eBooks · doi:10.5772/2354 · Cited by 66
Garbayo, E., Ansorena, E., Lana, H., Carmona‐Abellán, M., Marcilla, I., Lanciego, J. L., Luquín, M. R., & Blanco‐Prieto, M. J. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.09.015 · Cited by 65
In silico methods for design of biological therapeutics
Roy, A., Nair, S. A., Sen, N., Soni, N., & Madhusudhan, M. S. (2017) · Methods · doi:10.1016/j.ymeth.2017.09.008 · Cited by 62
Dutt, Y., Pandey, R. P., Dutt, M., Gupta, A. A., Vibhuti, A., Raj, V. S., Chang, C.-M., & Priyadarshini, A. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215251 · Cited by 64
Nanoparticle Based Treatment for Cardiovascular Diseases
Gupta, P., Garcia, E., Sarkar, A., Kapoor, S., Rafiq, K., Chand, H. S., & Jayant, R. D. (2018) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/1871529x18666180508113253 · Cited by 62
Sánchez‐Trasviña, C., Flores-Gatica, M., Enriquez-Ochoa, D., Rito‐Palomares, M., & Mayolo‐Deloisa, K. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.717326 · Cited by 63
Boulet-Audet, M., Byrne, B., & Kazarian, S. G. (2014) · Analytical Chemistry · doi:10.1021/ac502529q · Cited by 61
Yang, W., Wei, Y., Yang, L., Zhang, J., Zhong, Z., Storm, G., & Meng, F. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.10.013 · Cited by 59
Bhattacharyya, S., & Ghosh, S. S. (2020) · ACS Omega · doi:10.1021/acsomega.9b03531 · Cited by 59
Bio‐inspired functional coacervates
Chen, S., Guo, Q., & Yu, J. (2022) · Aggregate · doi:10.1002/agt2.293 · Cited by 61
Nanotechnology as a tool to overcome macromolecules delivery issues
Tundisi, L. L., Ataide, J. A., Costa, J. S. R., Coêlho, D. D. F., Liszbinski, R. B., Lopes, A. M., Nascimento, L. D. O., de Jesus, M. B., Jozala, Â. F., Ehrhardt, C., et al. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.113043 · Cited by 61
A Simple and Rapid Method for Preparing a Cell-Free Bacterial Lysate for Protein Synthesis
Krinsky, N., Kaduri, M., Shainsky‐Roitman, J., Goldfeder, M., Ivanir, E., Benhar, I., Shoham, Y., & Schroeder, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165137 · Cited by 58
Poly(lactic acid) for delivery of bioactive macromolecules
James, R., Manoukian, O. S., & Kumbar, S. G. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.06.009 · Cited by 57
Yang, H. Y., Jang, M.-S., Li, Y., Lee, J. H., & Lee, D. S. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b03747 · Cited by 57
Valko, K. L., & Ciesla, L. M. (2019) · Progress in medicinal chemistry · doi:10.1016/bs.pmch.2018.12.001 · Cited by 61
Tryfonidou, M. A., de Vries, G., Hennink, W. E., & Creemers, L. B. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.10.012 · Cited by 56
Wan, X., Zhang, J., Yu, W., Shen, L., Ji, S., & Hu, T. (2016) · Process Biochemistry · doi:10.1016/j.procbio.2016.09.029 · Cited by 56
Injectables and Depots to Prolong Drug Action of Proteins and Peptides
Ibeanu, N., Egbu, R., Onyekuru, L., Javaheri, H., Khaw, P. T., Williams, G. R., Brocchini, S., & Awwad, S. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12100999 · Cited by 56
Zhang, Z., Chen, K., Ameduri, B. M., & Chen, M. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00350 · Cited by 56
Expression without boundaries: Cell-free protein synthesis in pharmaceutical research
Casteleijn, M. G., Urtti, A. O., & Sarkhel, S. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.04.005 · Cited by 55
Enzyme therapeutics for systemic detoxification
Liu, Y., Li, J., & Lu, Y. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.05.005 · Cited by 55
Cabrera, I., Elizondo, E., Esteban, O., Corchero, J. L., Melgarejo, M., Pulido, D., Córdoba, A., Moreno, E., Unzueta, U., Vázquez, E., et al. (2013) · Nano Letters · doi:10.1021/nl4017072 · Cited by 53
Clinical development of a novel CD1d-binding NKT cell ligand as a vaccine adjuvant
Padte, N. N., Li, X., Tsuji, M., & Vasan, S. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.11.009 · Cited by 52
He, J., Feng, M., Zhou, X., Ma, S., Jiang, Y., Wang, Y., & Zhang, H. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.06.008 · Cited by 52
PEGylation and its alternatives
Abbina, S., & Anilkumar, P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-08-101750-0.00014-3 · Cited by 53
Novel site-specific PEGylated L-asparaginase
Meneguetti, G. P., Santos, J. H. P. M., Torres‐Obreque, K. M., Barbosa, C. M. V., Monteiro, G., Farsky, S. H. P., de Oliveira, A. M., Angeli, C. B., Palmisano, G., Ventura, S. P. M., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211951 · Cited by 51
Hassani, L. N., Hindré, F., Beuvier, T., Calvignac, B., Lautram, N., Gibaud, A., & Boury, F. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb20467g · Cited by 51
Pisal, D. S., Kosloski, M. P., Middaugh, C. R., Bankert, R. B., & Balu‐Iyer, S. V. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23091 · Cited by 47
Self-citationMahlumba, P., Choonara, Y. E., Kumar, P., du Toit, L. C., & Pillay, V. (2016) · Molecules · doi:10.3390/molecules21081002 · Cited by 48
Karumanchi, D. K., Skrypai, Y., Thomas, A. P., & Gaillard, E. R. (2018) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2018.07.003 · Cited by 48
Polyethylene Glycol Nanoparticles as Promising Tools for Anticancer Therapeutics
Mohapatra, A., Uthaman, S., & Park, I. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816963-6.00010-8 · Cited by 48
Product development issues for PEGylated proteins
Payne, R. W., Murphy, B. M., & Manning, M. C. (2010) · Pharmaceutical Development and Technology · doi:10.3109/10837450.2010.513990 · Cited by 47
PEGylated carbon nanotubes: preparation, properties and applications
Ravelli, D., Merli, D., Quartarone, E., Profumo, A., Mustarelli, P., & Fagnoni, M. (2013) · RSC Advances · doi:10.1039/c3ra40852c · Cited by 47
Salmaso, S., & Caliceti, P. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.12.029 · Cited by 47
Zou, X., Yuan, M., Zhang, T., Zheng, N., & Wu, Z. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.09.026 · Cited by 46
Polymer-mediated protein/peptide therapeutic stabilization: Current progress and future directions
Sivasankaran, R. P., Snell, K., Kunkel, G. E., Georgiou, P. G., Puente, E. G., & Maynard, H. D. (2024) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2024.101867 · Cited by 54
Yang, W., Xia, Y., Zou, Y., Meng, F., Zhang, J., & Zhong, Z. (2017) · Chemistry of Materials · doi:10.1021/acs.chemmater.7b02953 · Cited by 45
“Graft-to” Protein/Polymer Conjugates Using Polynorbornene Block Copolymers
Isarov, S. A., Lee, P. W., & Pokorski, J. K. (2016) · Biomacromolecules · doi:10.1021/acs.biomac.5b01582 · Cited by 45
Haggag, Y. A., Faheem, A., Tambuwala, M. M., Osman, M. A., El‐Gizawy, S. A., O’Hagan, B. M. G., Irwin, N., & McCarron, P. A. (2017) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2017.1295066 · Cited by 45
Engineering Nanomaterials for Smart Drug Release
Singh, A. K., Yadav, T. P., Pandey, B., Gupta, V., & Singh, S. P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814029-1.00015-6 · Cited by 47
Özer, İ., Pitoc, G. A., Layzer, J. M., Moreno, A., Olson, L. B., Layzer, K. D., Hucknall, A., Sullenger, B. A., & Chilkoti, A. (2022) · Advanced Materials · doi:10.1002/adma.202107852 · Cited by 46
The EPR Effect in Cancer Therapy
Yhee, J. Y., Son, S., Son, S., Joo, M. K., & Kwon, I. C. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7876-8_23 · Cited by 45
Chia, S., Tay, S. J., Song, Z., Yang, Y., Walsh, I., & Pang, K. T. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114757 · Cited by 46
Intracellular antibodies and cancer: New technologies offer therapeutic opportunities
Pérez-Martínez, D., Tanaka, T. U., & Rabbitts, T. H. (2010) · BioEssays · doi:10.1002/bies.201000009 · Cited by 44
Ophthalmic Uses of a Thiol-Modified Hyaluronan-Based Hydrogel
Wirostko, B. M., Mann, B. K., Williams, D. L., & Prestwich, G. D. (2014) · Advances in Wound Care · doi:10.1089/wound.2014.0572 · Cited by 44
Polyion Complex Micelles for Protein Delivery*
Chen, F., & Stenzel, M. H. (2018) · Australian Journal of Chemistry · doi:10.1071/ch18219 · Cited by 45
Peng, A., Pisal, D. S., Doty, A. C., & Balu‐Iyer, S. V. (2011) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2011.10.002 · Cited by 42
Self-citationTao, A., Huang, G. L., Igarashi, K., Hong, T., Liao, S., Stellacci, F., Matsumoto, Y., Yamasoba, T., Kataoka, K., & Cabral, H. (2019) · Macromolecular Bioscience · doi:10.1002/mabi.201900161 · Cited by 43
Targeted nanomedicines for the treatment of bone disease and regeneration
Ordikhani, F., Zandi, N., Mazaheri, M., Luther, G. A., Ghovvati, M., Akbarzadeh, A., & Annabi, N. (2020) · Medicinal Research Reviews · doi:10.1002/med.21759 · Cited by 45
Saux, S. L., Aubert‐Pouëssel, A., Mohamed, K. E., Martineau, P., Guglielmi, L., Devoisselle, J., Legrand, P., Chopineau, J., & Morille, M. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113837 · Cited by 48
A Solvent-Free Thermosponge Nanoparticle Platform for Efficient Delivery of Labile Proteins
Choi, W. I., Kamaly, N., Riol‐Blanco, L., Lee, I.-H., Wu, J., Swami, A., Vilos, C., Yameen, B., Yu, M., Shi, J., et al. (2014) · Nano Letters · doi:10.1021/nl502994y · Cited by 43
Recent application of analytical methods to phase I and phase II drugs development: a review
Locatelli, M., Governatori, L., Carlucci, G., Genovese, S., Mollica, A., & Epifano, F. (2011) · Biomedical Chromatography · doi:10.1002/bmc.1674 · Cited by 42
Hydrophobic interaction chromatography for purification of monoPEGylated RNase A
Mayolo‐Deloisa, K., Lienqueo, M. E., Andrews, B. A., Rito‐Palomares, M., & Asenjo, J. A. (2012) · Journal of Chromatography A · doi:10.1016/j.chroma.2012.03.079 · Cited by 42
Controlled bone formation using ultrasound-triggered release of BMP-2 from liposomes
Crasto, G. J., Kartner, N., Reznik, N., Spatafora, M. V., Chen, H., Williams, R., Burns, P. N., Clokie, C. M. L., Manolson, M. F., & Peel, S. A. F. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.09.032 · Cited by 42
Advancements and Challenges in Multidomain Multicargo Delivery Vehicles
Pugliese, E., Coentro, J. Q., & Zeugolis, D. I. (2018) · Advanced Materials · doi:10.1002/adma.201704324 · Cited by 42
Nanodrug removes physical barrier to promote T-cell infiltration for enhanced cancer immunotherapy
Xiao, Z., Tan, Y., Cai, Y., Huang, J., Wang, X., Li, B., Lin, L., Wang, Y., Shuai, X., & Zhu, K. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.02.029 · Cited by 42
Plowright, A. T., Engkvist, O., Gill, A. L., Knerr, L., & Wang, Q. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201307034 · Cited by 41
Styslinger, T. J., Zhang, N., Bhatt, V. S., Pettit, N., Palmer, A. F., & Wang, P. G. (2012) · Journal of the American Chemical Society · doi:10.1021/ja300893t · Cited by 41
Intracellular targeting with engineered proteins
Miersch, S., & Sidhu, S. S. (2016) · F1000Research · doi:10.12688/f1000research.8915.1 · Cited by 43
Ruderfer, I., Shulman, A., Kizhner, T. A., Azulay, Y., Nataf, Y., Tekoah, Y., & Shaaltiel, Y. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00133 · Cited by 41
Bioconjugation in Drug Delivery: Practical Perspectives and Future Perceptions
Elzahhar, P. A., Belal, A. S. F., ElAmrawy, F., Helal, N. A., & Nounou, M. I. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9516-5_11 · Cited by 41
Ahmed, S. G., Fujita, S., & Matsumura, K. (2016) · Nanoscale · doi:10.1039/c6nr03940e · Cited by 40
Liposomes and phytosomes for phytoconstituents
Karpuz, M., Silindir‐Gunay, M., & Özer, A. Y. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819666-3.00018-3 · Cited by 40
Yan, J., Yang, S., Sun, H., Guo, D., Wu, B., Ji, F., & Zhou, D. (2013) · Journal of Biomaterials Applications · doi:10.1177/0885328213515034 · Cited by 40
Solomevich, S. O., Oranges, C. M., Kalbermatten, D. F., Schwendeman, A. A., & Madduri, S. (2023) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2023.120934 · Cited by 39
Jensen, S. S., Jensen, H. M., Møller, E. H., Cornett, C., Siepmann, F., Siepmann, J., & Østergaard, J. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.10.011 · Cited by 39
Intermolecular interactions in highly concentrated formulations of recombinant therapeutic proteins
Baek, Y., & Zydney, A. L. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.12.016 · Cited by 39
Honda, Y., Nomoto, T., Matsui, M., Takemoto, H., Kaihara, Y., Miura, Y., & Nishiyama, N. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.0c00903 · Cited by 40
Smart Stimuli-Responsive Biopolymeric Nanomedicines for Targeted Therapy of Solid Tumors
Fathi, M., Abdolahinia, E. D., Barar, J., & Omidi, Y. (2020) · Nanomedicine · doi:10.2217/nnm-2020-0146 · Cited by 40
Enhanced cell adhesion on silk fibroin via lectin surface modification
Teuschl, A., Neutsch, L., Monforte, X., Rünzler, D., van Griensven, M., Gabor, F., & Redl, H. R. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2014.02.012 · Cited by 39
Next Generation Delivery System for Proteins and Genes of Therapeutic Purpose: Why and How?
Sharma, A. R., Kundu, S. K., Nam, J., Sharma, G., Doss, C. G. P., Lee, S., & Chakraborty, C. (2014) · BioMed Research International · doi:10.1155/2014/327950 · Cited by 41
Abdel‐Moneim, A., & Ramadan, H. (2021) · Drug Development Research · doi:10.1002/ddr.21903 · Cited by 40
Corvo, M. L., Marinho, H. S., Marcelino, P. A., Lopes, R. M., Vale, C., Marques, C. R., Martins, L. C. D., Laverman, P., Storm, G., & Martins, M. B. F. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1447-7 · Cited by 38
Enhanced catalysis of l-asparaginase from Bacillus licheniformis by a rational redesign
Sudhir, A. P., Agarwaal, V. V., Dave, B. R., Patel, D., & Subramanian, R. B. (2016) · Enzyme and Microbial Technology · doi:10.1016/j.enzmictec.2015.11.010 · Cited by 38
Reactive Self-Assembly of Polymers and Proteins to Reversibly Silence a Killer Protein
Ventura, J., Eron, S. J., González-Toro, D. C., Raghupathi, K., Wang, F., Hardy, J. A., & Thayumanavan, S. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b00779 · Cited by 36
Ashrafi, H., Amini, M., Mohammadi‐Samani, S., Ghasemi, Y., Azadi, A., Tabandeh, M. R., Kamali‐Sarvestani, E., & Daneshamouz, S. (2013) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2013.08.028 · Cited by 37
Metadata
- Authors
- Pisal, D. S., Kosloski, M. P., & Balu-Iyer, S. V.
- Affiliations
- University at Buffalo, State University of New York (US)
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2010-06
- Volume
- 99
- Issue
- 6
- Pages
- 2557-2575
- ISSN
- 0022-3549 (ISSN-L)
- PMC
- PMC2857543
- OpenAlex
- W1985516113
- Cited by
- 532
- References
- 160
- Citations by year
- 2026: 8 · 2025: 19 · 2024: 14 · 2023: 38 · 2022: 25 · 2021: 31 · 2020: 42 · 2019: 44 · 2018: 45 · 2017: 43 · 2016: 48 · 2015: 40 · 2014: 48 · 2013: 26 · 2012: 28
- FWCI
- 3.81
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Pharmaceutical Sciences (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Pfizer
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL070227, HL-70227)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
- Keywords
- therapeutic proteins, drug delivery, protein stability, immunogenicity, protein half-life, PEGylation, polysialic acid, glycolic acid, nanoparticle drug delivery, liposomes, polymeric nanoparticles, polymer microspheres, colloidal drug delivery
- MeSH terms
- Chemistry, Pharmaceutical, Half-Life, Humans, Liposomes, Microspheres, Polyethylene Glycols, Polymers, Proteins, Sialic Acids, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review